Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
Slika profila

Josip Joachim Grah

30786

Josip Joachim

Grah

dr. sc.

nije evidentirano
Naziv Akcije
Galunić Bilić, Lea ; Šantek, Fedor ; Grah, Josip Joachim ; Bašić-Kinda, Sandra ; Mandac Smoljanović, Inga ; Ostojić Kolonić, Slobodanka ; Mitrović, Zdravko ; Vodanović, Marijo ; Dujmović, Dino ; Aurer, Igor Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience // Radiologia medica, 128 (2023), 1615, 9. doi: 10.1007/s11547-023-01615-8
Galunić Bilić, Lea ; Šantek, Fedor ; Soče, Majana ; Grah, Josip Joachim ; Bašić Kinda, Sandra ; Radman, Ivo ; Mitrović, Zdravko ; Martinović, Marko ; Aurer, Igor Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients // Radiotherapy and oncology. 2020. str. S486-S486 doi: 10.1016/S0167-8140(21)00927-0
Katalinic, Darko ; Grah Josip Joachim Immunohistochemical expression of MAGE-A1, MAGE- A3/4 and NY-ESO-1 antigens in patients with non- small cell lung cancer: Is there any impact on the specific immunotherapy? // European journal of cancer (1990). 2017. str. 2064-2064 doi: 10.1016/S0959-8049(17)30673-1
Katalinic, Darko ; Grah, Josip Joachim Immunohistochemical expression of MAGE-A1, MAGE- A3/4 and NY-ESO-1 antigens in patients with non- small cell lung cancer: Is there any impact on the specific immuntherapy? // European journal of cancer (1990) / Eggermont, Alexander M.M. (ur.). 2017. str. 186-186 doi: 10.1016/S0959-8049(17)30673-1
Radić, Jasna ; Krušlin, Božo ; Šamija, Mirko ; Ulamec, Monika ; Milošević, Milan ; Jazvić, Marijana ; Šamija, Ivan ; Grah, Josip Joachim ; Bolanča, Ante ; Kusić, Zvonko Connexin 43 Expression in Primary Colorectal Carcinomas in Patients with Stage III and IV Disease // Anticancer Research, 36 (2016), 5; 2189-2196
Katalinic, Darko ; Santek, Fedor ; Juretic, Antonio ; Stern-Padovan, Ranka ; Nikolac, Nora ; Grah, Josip Joachim ; Plestina, Stjepko Ca 19-9: Is there a role for potential new biomarker for medullary thyroid cancer? // Endocrine abstracts. 2014
Grah, Josip Joachim ; Katalinić, Darko ; Juretić, Antonio ; Šantek, Fedor ; Samaržija, Miroslav Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer // Tumori, 100 (2014), 1; 60-68. doi: 10.1700/1430.15817
Aurer, Igor ; Bašić-Kinda, Sandra ; Radman, Ivo ; Ilić, Ivana ; Grah, Josip Joachim Burkitt lymphomas failing dose-adjusted R-EPOCH (DA-R-EPOCH) // Annals of hematology, 93 (2014), 1; 177-178. doi: 10.1007/s00277-013-1771-8
Juretic, Antonio ; Puco, Katarina ; Bisof, Vesna ; Katalinic, Darko ; Rakusic, Zoran ; Santek, Fedor ; Grah, Josip Joachim Imunoterapija uroloskih tumora // Urološki simpozij : knjiga sazetaka /. Zagreb: Hrvatsko onkološko društvo, 2013. str. 35-39
Santek, Fedor ; Loncar, Kresimir ; Katalinic, Darko ; Juretic, Antonio ; Soce, Majana ; Grah, Josip-Joachim, Herceg, Tonko The abilities and the complications of the modern chemo/radio/immunotherapy approach in treatment of malignant gliomas // Abstract Book - 3rd SEEC Chemotherapy and Infections. Dubrovnik, 2012
nije evidentirano
nije evidentirano